A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the standard salbutamol inhaler in children with mild asthma, cutting attacks by ...
For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...
New Scientist on MSN
Two-in-one inhalers slash asthma attacks among young children
Inhalers that combine relieving breathlessness with preventing it seem to be the most effective option for reducing asthma attacks in young children ...
Findings could redefine the treatment for millions of children worldwide with asthma, after this comparison of two types of asthma inhalers.
In the first randomised controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be ...
In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be ...
A NIGHT out with friends ended in tragedy when Zoe Nunn died after suffering an asthma attack. The family of the 20-year-old student are now urging others to take the condition seriously. Zoe was ...
News-Medical.Net on MSN
2-in-1 budesonide-formoterol inhaler reduces children's asthma attacks by 45%
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated.
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm Adherium, ...
MedPage Today on MSN
Reliever Combo Inhaler Better Than SABA Alone for Kids' Mild Asthma
As reliever monotherapy for mild asthma, the inhaled corticosteroid (ICS)-formoterol combination reduced asthma attacks in children compared with a short-acting β₂-agonist (SABA), the CARE trial ...
(UroToday.com) The 67 th American Society for Radiation Oncology (ASTRO) annual meeting held in San Francisco, was host to the Quality of Life Outcomes after Prostate Radiotherapy session. Dr. Daniel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results